← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
The Council Of The Queensland Institute Of Medical Research
$4,893,197
Total funding
9
Grants
Funding over time
peak $1.2M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$4,893,197 · 9
By mechanism
—$4,893,197 · 9
Investigators at The Council Of The Queensland Institute Of Medical Research
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
THE NOSE KNOWS: HARNESSING HUMAN OLFACTORY CELLS TO IDENTIFY BIOMARKERS OF NONMOTOR CHANGES IN PARKINSON'S DISEASE$1,173,445
· FY2024 · Defense Health Agency
OPTIMAL DOSE, VOLATILE PYRETHROIDS FOR PREVENTION OF BITING INSECTS.$1,085,325
· FY2015 · Department of the Army
ADVANCED PATIENT-DERIVED MICROGLIA ASSAY FOR PRECLINICAL AND CLINICAL TRIAL DRUG VALIDATION$659,568
· FY2022 · Defense Health Agency
PROOF-OF-CONCEPT STUDIES FOR A NOVEL IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER AND COMPANION DIAGNOSTIC$477,231
· FY2025 · Defense Health Agency
USING GENETICS TO IDENTIFY NEW ENDOMETRIAL CANCER THERAPEUTICS$439,692
· FY2025 · Defense Health Agency
TARGETING CEP55 IN TRIPLE-NEGATIVE BREAST CANCER$439,609
· FY2022 · Defense Health Agency
UNDERSTANDING THE EXTRACELLULAR VESICLE-MEDIATED MECHANISM (S) OF RESISTANCE IN ADVANCED PROSTATE CANCER$300,395
· FY2016 · Department of the Army
SYSTEMATIC IDENTIFICATION, VALIDATION, AND EVALUATION OF BREAST CANCER RISK GENES THROUGH FOLLOW UP OF GENOME WIDE ASSOCIATION STUDIES$236,998
· FY2019 · Department of the Army
THE ROLE OF ADENOSINE A2BR IN METASTATIC MELANOMA$80,934
· FY2016 · Department of Defense